Evaluation for Therapeutic Plasma Exchange for Immune Mediated Neurological Disease

Recruiting now

Conditions studied: Neurological Autoimmune Diseases

In brief

The goal of this observational study is to Evaluation of Therapeutic Plasma Exchange for Immune-Mediated Neurological Diseases in a Sample of Egyptian Patients: An Experience at Al-Azhar University Hospitals, including evaluating clinical response rates and functional improvement.

Key facts

Study ID

NCT07197099

Run by

Al-Azhar University

People needed

60

Starts

2025-01-01

Expected to finish

2025-12-31

Last updated by the study team

2025-11-18

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• 1. All neurological patients irrespective of age who will undergo TPE. 2.All new and relapse cases that meet the ASFA guidelines and where TPE is the first and/or second line of therapy

You may not qualify if…

• 1. Individuals with contraindications to therapeutic plasma exchange, such as hemodynamic unstable, hypocalcaemia, allergy to fresh frozen plasma or albumin.
• Patients who will undergo fewer than five cycles of TPE and not complete the procedure.
• Patients with non-neurological disorders.

Where it is running

• Al-Azhar University Hospitals — Cairo, Egypt (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.